NCT00017628View on ClinicalTrials.gov

Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2001

Conditions

Multiple Sclerosis

Interventions

DRUG

cyclophosphamide

DRUG

filgrastim

DRUG

methylprednisolone

PROCEDURE

Autologous Stem Cell Transplantation

Trial Locations (2)

60611

Northwestern Memorial Hospital, Chicago

60612

Rush-Presbyterian-St. Luke's Medical Center, Chicago

All Listed Sponsors

lead

Northwestern Memorial Hospital

OTHER

NCT00017628 - Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis | Biotech Hunter | Biotech Hunter